Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic System for Hyperviscosity Syndrome in Waldenström Macroglobulinemia
NCT04898647Recruiting
- Sponsor
- CHU Amiens-Picardie
- Start
- May 2021
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Amiens-Picardie. Primary endpoints: Correlation between items collected in questionnaires and HVS detection at 3 years and Correlation between fundoscopic findings and HVS detection at 3 years. Started May 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04898647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04898647.